William Wei Cao, chairman and CEO of Gracell, shares the fascinating journey that inspired him to establish Gracell in Shanghai to tackle the four big challenges facing the global CAR-T industry; the four novel technology platforms Gracell is working on that are already drawing significant investor and Big Pharma interest; and the mission of Gracell to deliver affordable and accessible CAR-T therapies to meet global patient needs through non-exclusive collaborations.
The CAR-T industry is still in its infancy and I realized there were still many imperfections with the technology
